LEP Biomedical
Biotechnology Research • 
Naas, Co Kildare, Ireland • 1-10 Employees
Company overview
| Headquarters | Naas, Co Kildare, Ireland |
| Website | |
| NAICS | 541714 |
| Keywords | Drug Delivery, Glaucoma, Cataracts, Inflammation, Wound Healing |
| Founded | 2023 |
| Employees | 1-10 |
| Socials |
Key Contact at LEP Biomedical
Alan Hibbitts
Founder & CEO
About LEP Biomedical
LEP Biomedical's core mission is to make glaucoma drainage surgeries 100% successful and relieve the burden associated with post-surgery follow up care. LEP Biomedical specializes in local ophthalmic drug delivery. Specifically,"HyaGuard" is our biodegradable solution designed to replace patient-administered anti-inflammatory drops. HyaGuard is also designed to be compatible with traditional trabeculectomy surgeries or drainage tubes. HyaGuard is rapidly and easily inserted into the sub-conjunctival space at the end of a standard surgery. Here, it delivers anti-inflammatory drugs in a controlled manner. This is intended to eliminate the need for self-administered anti-inflammatory drops, decrease post-surgical complications and improve patient quality of life.
LEP Biomedical revenue & valuation
| Annual revenue | $256,665 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $821,328 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
LEP Biomedical has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
LEP Biomedical has never raised funding before.
United States
Belgium
NetherlandsFrequently asked questions
4.8
40,000 users
